Animal Pharm Podcast #17: Improved investment environment still needs specialized funds
Animal Pharm's most recent webinar highlighted the ongoing paucity of specialized investors in the animal health sector.
The podcast below is a recording of the webinar, which focused on the trends shaping the current landscape of animal health investment. Animal Pharm editor Joseph Harvey spoke to Charles Hoare (head of European healthcare investment banking at Stifel), Phil Austin (founding partner at Anterra Capital) and Jochem Bossenbroek (chief executive of Dutch start-up BunyaVax) about a variety of subjects during the webinar.
While recent years have witnessed an improved environment for funding in the animal health sector, this has largely come from investors with portfolios across multiple sectors.
The presentation is also available here.
The topics covered during the webinar included:
The investment community's stance on the animal health sector;
The portions of the industry ripe for investment;
The main obstacles to funding;
Advice for start-ups seeking investment;
The level of support offered to start-ups by the larger animal health companies;
The viability of funding for the animal microbiome space; and
Mega-mergers and IPOs.